Affiliation:
1. Qingdao University
2. Yantai Yuhuangding Hospital
3. Linyi People's Hospital
Abstract
Abstract
Background
Macronutrients play a vital role in liver dysfunction and affect the treatment and prognosis of tuberculosis. This study aimed to clarify the associations between macronutrients intakes or to energy percentages and liver dysfunction in tuberculosis patients.
Methods
In this cross-sectional study, 2695 active tuberculosis patients aged ≥ 18 years were included based on the data from local tuberculosis clinics in Linyi rural areas, China. Macronutrients intakes and to energy percentages were assessed by the 24-hour dietary recalls. The concentration of alanine transferase (ALT) or aspartate transaminase (AST) greater than 40 U/L was defined liver dysfunction. In addition, restricted cubic spline (RCS) was applied to determine the dose-response relationships.
Results
Among those who were male, or normal BMI, or consumed energy less than 1646.80 kcal/d, it was suggested both inverse associations between protein (47.30–78.80 g/d) or fat (> 20.30 g/d) intake and the risks of liver dysfunction in all models (all P-trend < 0.05). Moreover, the RCS model showed J-shaped associations between protein, fat intake, the fat or carbohydrate to energy percentages and the odds of liver dysfunction (the cut-off values = 70.69 g/d, 47.50 g/d, 22% and 69%, respectively, and all P-nonlinearity < 0.05).
Conclusions
An appropriate increase in dietary intakes of protein or fat might reduce liver dysfunction risk. However, intakes of more than 70.69 g/d for protein or 47.50 g/d for fat could increase the risk of liver dysfunction. Our study may provide a novel idea of alleviating liver dysfunction with nutritional improvement.
Publisher
Research Square Platform LLC
Reference59 articles.
1. Organization WH. Global Tuberculosis Report 2022. Geneva: World Health Organization 2022.
2. Impact of the gate-keeping policies of China's primary healthcare model on the future burden of tuberculosis in China: a protocol for a mathematical modelling study;You X;BMJ Open,2021
3. Assessing the prevalence and effect of adverse drug reactions among patients receiving first line anti-tubercular medicines in the Tamale Teaching Hospital, Ghana;Amalba A;Pan Afr Med J,2021
4. Incidence and risk factors of anti-tuberculosis drug induced liver injury (DILI): Large cohort study involving 4652 Chinese adult tuberculosis patients;Jiang F;Liver Int,2021
5. Drug-Induced Liver Injury from Anti-Tuberculosis Treatment: A Retrospective Cohort Study;Zhao H;Med Sci Monit,2020